Matters related science and technology related to vitamins, minerals, herbs, phytochemicals, hormones, and intermediate metabolites

Matters related science and technology related to vitamins, minerals, herbs, phytochemicals, hormones, and intermediate metabolites.

Moxie Industry, Inc. 1984-86. Vice President in charge of matters related science and technology, and product development in vitamins, minerals, herbs, phytochemicals, hormones, intermediate metabolites, and regulatory affairs.
Richardson-Vicks, Inc.--Natural Product Division. 1982-84. Vice President and Director of Nutrition in charge of matters related to the sciences and technology of vitamins, minerals, herbs, phytochemicals, hormones, intermediate metabolites), and development of drugs and dietary supplements.
PepsiCo, Inc./Frito-Lay. 1975-82. Chief Scientist in charge research in biomedical, nutritional, and food science; and development of new nutritional and food products.
Worthington Biochemical Division of Millipore, Inc. 1973-75. Director of Research in charge of research in application of enzyme in biomedical field and development of products for enzyme treatment and diagnosis of diseases.
GTE Laboratories. 1972-73. Manager of Life Sciences in charge of biomedical research, including biomedical effects of nonionizing radiations, development of medical equipments.
Professional Activities:           Founding member and a current Director of the Certification Board for Nutrition Specialist. Hve written many questions for the certification examinations to be taken by candidate nutritionists with advanced degrees and 3 years of experience.
Advisor, Chinese Society of Food Science and Technology.
Organized and Chaired the session on biological oxidation in health and disease of the 6th World Congress on Clinical Nutrition. 1997. Canada.
A member of the Nutrition Federation of California.
Organized the First World Congress on the Health Significance of Garlic and Garlic Constituents. 1990. Washington, D.C.
Organized the session on nutrition of the 7th World Congress of Food Science and Technology. 1987. Singapore.
Organized and Chair a conference on the nutritional and medicinal properties of Chinese medicinal herbs. 1977. San Francisco.
Professional Membership: American College of Nutrition.
International College of Nutrition (Fellow).
American College of Sports Medicine.
Sigma Xi/Research Society of America (life member). New York Academy of Sciences (life member). The Nutrition Society (Republic of China).
The Obesity Society (China).
1.         Steiner M, Khan AH, Holbert D, Lin RIS. 1996. Abouble-blind crossover study in moderately hypocholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Din Nutr 64:866-70.
2.         Lin JUL. Comments on standardization of garlic products. A chapter in the Proceedings of The First World Congress on the Health Significance of Garlic and Garlic Constituents. 1990.
3.         Lin, R.I.S. 1987. Lipid Nutrition and Cardiovascular Diseases. in Trends in Nutrition and Food Policy, A.H. Ghee ed.-in-Chief, K.W. Lu and K.A. Kim eds. Singapore National University Press.
4.         Lin RIS. 1986. Garlic: New Perspectives. A book available form Nutrition International Co. P.O. Box 50632, CA 92619-0632, U.S.A.
5.         Qureshi AA, Lin RIS, Abuirmeileh N, and Qureshi N. Inhibition of cholesterol synthesis by Kyolic (aged garlic extract) and S-allyl cysteine in a hypercholesterolemic model. A chapter in the Proceedings of The First World Congress on the Health Significance of Garlic and Garlic Constituents. 1990.
6.         Qureshi N, Lin RIS, Abuirmeileh N, and Qureshi AA. Dietary Kyolic (aged garlic extract) and S-allyl cysteine reduces the level of plasma triglycerides, thromboxane B2 and platelet aggregation in a hypercholesterolemic model. A chapter in the Proceedings of The First World Congress on the Health Significance of Garlic and Garlic Constituents. 1990.
7.         Lee ES, Steiner M, and Lin RIS. Thioallyl compounds: Potent inhibitors of cell proliferation. Biochim Biophys 1994; 1221:73-77.
8.         Freeman F, Huang GB, Lin RIS. Garlic Chemistry. Nitric oxide oxidation of S-(2propenyl)cysteine and (+)-S-(2-propenyl)-L-cysteine sulfoxide. J Org Chem 1994; 59:3227-9.
9.         Liu J, Lin RI, Milner JA. Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary tumors and DNA adducts by garlic powder. Carcinogenesis 1992; 13:184751.
10.       Li G, Qiao CH, Lin RI, Pinto J, Osborne MP, Tiwari RK. Anti-proliferative effects of garlic constituents in cultured human breast cancer cells. Oncology Rep 1995; 2:78791.
11.       Hoon DSB, Sze L, Lin RI, Irie RF. Modulation of cancer antigens and growth of human melanoma by aged garlic extract. A chapter in the Proceedings of The First World Congress on the Health Significance of Garlic and Garlic Constituents. 1990.
12.       Lin RIL, Phytochemicals and Antioxidants. A chapter in Functional Foods, 1. Goldberg, ed., Chapman & Hall, New York. 1994
13.       Shjeide A & Lin RIL. Synthesis of Cytomembranes. A chapter in Cell Differentiation. Shjeide A & De Vries, ed. Mosby, New York. 1969.
Lucinda Glantz Mi11er, PhamiD, BCPS
CURRICULUM VITAE
January 1999
I.          GENERAL BIOGRAPHICAL INFORMATION
NAME:           Lucinda Glantz Miller
BIRTHDATE:            August 7, 1957
HOME ADDRESS:   3531 Beau Brurnmel Dr. Amarillo, TX 79121
BUSINESS ADDRESS:        Department of Pharmacy Practice School of Pharmacy
Texas Tech University Health Science Center 1300 Coulter
Amarillo, TX 79106-1712
(806)356-4000 x 282
EDUCATION AND TRAINING:
1980    Doctor of Pharmacy (Pharm.D.) University of Nebraska Medical Center College of Pharmacy
42nd and Dewey
Omaha, Nebraska 68105
1975-77           Kearney State College Kearney, Nebraska 68447
ACADEMIC APPOINTMENTS:
1997-present   Professor and Vice-Chair, Primary Care Department of Pharmacy Practice
School of Pharmacy
Texas Tech University Health Sciences Center Amarillo, Texas
1997-1998       Interim Associate Dean for Clinical Research School of Pharmacy
Texas Tech University Health Sciences Center Amarillo, Texas
1993-1997       Director, Nebraska Drug Information Network Associate Professor
Department of Pharmacy Practice College of Pharmacy
University of Nebraska Medical Center Omaha, Nebraska
1987-1993       Assistant Professor of Family Medicine Department of Family Medicine
Baylor College of Medicine
Houston, Texas
1990-1993       Adjunct Assistant Professor in Behavioral Sciences
School of Public Health
University of Texas at Houston Houston, Texas
1990-1993       Adjunct Professor of Pharmaceutics College of Pharmacy
-University of Houston
Houston, Texas
1983-1993       Adjunct Assistant Professor of Clinical Pharmacy Practice
College of Pharmacy University of Houston Houston, Texas
SPECIALIZED TRAINING:
1987    Clinical Pharmacokinetics Training Program University of Florida
Gainesville, Florida, May 1987
1991    Minnesota Multiphasic Personality Inventory-2 (MMPI-2), workshop and symposium, Department of Psychology, University of Minnesota, San Antonio, TX, January 18-19, 1991
1996    Multimedia and Internet Technology for Pharmacy Education, Third Annual Teaching Academy, University of Texas, Austin, TX, May 19-22, 1996.
AWARDS:
1)         Texas "Doer" Award; Carl Terzian Associates in association with Houston Metropolitan Magazine; award recognizing Texas leaders in business, civic, cultural, and philanthropic activities, 1989.
2)         Leonard D. Moise Teaching Award (outstanding family medicine faculty award). Department of Family Medicine, Baylor College of Medicine, 1991.
3)         NIMH Child and Adolescent Mental Disorders Research Consortium, 2nd Technical Assistance Workshop for Promising New Investigators; acceptance based on research concept paper entitled, "Attention deficit hyperactivity disorder (ADHD) and chronobiology: implications for family dynamics and child/parental "goodness of fit", one of 3 papers on ADHD accepted, March 16-18, 1992.
BOARD CERTIFICATION: Board Certified Pharmacotherapy Specialist, 1991, #291123
Renewed 1998
PROFESSIONAL LICENSURE: Kansas 1980 Texas 1981
Nebraska 1993
RADIATION SAFETY         Texas Tech University Health Sciences Center
CERTIFICATE:         Lubbock, Texas June 1998
INVENTIONS:          1)         Miller LG. Medication Record, United States Patent 4,932,682 (issued June 12, 1990).
2)         Miller LG. Nebraska Pharmacist Intervention Document, computer software program, copyright 1994.
PROFESSIONAL POSITIONS:
1997-present   Professor and Vice-Chair, Primary Care Department of Pharmacy Practice
School of Pharmacy
Texas Tech University Health Sciences Center Amarillo, Texas
September 1993 to      Director, Nebraska Drug Information Network
1997    Associate Professor
Department of Pharmacy Practice College of Pharmacy
University of Nebraska Medical Center Omaha, Nebraska
May 1987 to    Assistant Professor
May 1993        Department of Family Medicine Baylor College of Medicine Houston, Texas
April 1985 to   Coordinator of Drug Information and
March 1987     Staff Development Department of Pharmacy The Methodist Hospital Texas Medical Center Houston, Texas
November 1983          Assistant Director
to March 1985 Turner Drug Information Center University of Houston
College of Pharmacy
Houston, Texas
October 1982 Drug Information Specialist
to Nov. 1983   Turner Drug Information Center University of Houston
College of Pharmacy
Houston, Texas
September 1981          Staff Pharmacist
to Oct. 1982    Park Plaza Hospital Houston, Texas
June 1980 to    Staff Pharmacist
August 1981   St. Joseph Medical Center Wichita, Kansas
II.        Funded Grant Proposals
1. "Provision of Information on Drugs as Possible Teratogens to Health Care Practitioners and to the General Public, "Lucinda G. Miller, PharmD (PI), March of Dimes; Houston Chapter, $5,000, November 1984-October 1985.
2.         "Comparative Safety and Efficacy of Abbott-56268 and Erythromycin in the Treatment of Outpatients with Community-Acquired Pneumonia", Christine C. Matson MD (PI), Lucinda G. Miller PharmD (Co-I), Thomas Kettler MD (Co-I), Abbott Laboratories, $46,000. October 1987 - March 1989.
3.         "A Comparative Trial of BMY-28100 (250mg BID) versus Cefaclor (250 mg TID) versus Norfloxacin (400mg BID) in the Treatment of Acute and Uncomplicated Urinary Tract Infections", Lucinda G. Miller PharmD (PI), John G. Prichard MD (Co-I), MHS, Michael Noel, MD (Co-I). Bristol-Myers Company, $21,000, November 1987-September 1988.
4.         "A Comparative Trial of BMY-28100 (500mg daily) versus Cefaclor (250mg TI)) versus Norfloxacin (400mg BID) in the Treatment of Acute and Uncomplicated Urinary Tract Infections", Lucinda G. Miller PharmD (PI), John G. Prichard MD (Co-I), Michael Noel, MD (Co-I). Bristol-Myers Company, $45,900, September 1988-August 1989.
5.         "An Open-Label Study of Diclofenac Treatment vs. Sulindac in Patients with Osteoarthritis", Lucinda G. Miller PharmD (PI), Robert C. Bowman, MD (Co-I), Ciba-Geigy, Pharmaceutical Division, $10,000, December 1987 - July 1988.
6.         "Pharmacokinetic Evaluation of Concurrent Administration of Sucralfate and Erythromycin Ethylsuccinate", Lucinda G. Miller PharmD (PI), John G. Prichard MD, MHS (Co-I). Baylor Family Medicine Research Award, $500, January - February 1988.
7.         "Drug-induced Nephropathy: Detection via Alanine Aminopeptidase". Lucinda G. Miller (PI), PharmD, Cynthia L. Chappell PhD (Co-I), Baylor Family Medicine Research Award, $1,200, July 1, 1988 - January 1, 1989.
8.         "Evaluation of Children with ADDH in a Summer Day Camp Setting: Temperament and Actigraph Analyses", Lucinda G. Miller PharmD (PI), Michael Smolensky PhD (Co-I), Irvin A. Kraft MD (Co-I), Lynn Malseed MD (Co-I), Kraft Research Fund, $5,000, June - August 1990.
9.         "A multicenter, placebo-controlled study evaluating the safety and efficacy of cilazapril in hypertension". Lucinda G. Miller PharmD (PI), Barry Carter, PharmD (Co-I), Fred Bakht, MD (Co-I), Hoffman-LaRoche Inc., $62,446. October 1989 - September 1990 (discontinued due to product efficacy problems).
10.       "Sleep laboratory evaluation of children with attention deficit disorder-hyperactivity (ADDH)". Lucinda G. Miller, PharmD (PI), Michael Smolensky,
PhD (Co-I), James Frost MD (Co-I), Irvin A. Kraft, MD (Co-I). Kraft Research Fund, $1,000, March 1991-February 1992.
11.       "Evaluation of medication effectiveness in children with attention deficit disorder-hyperactivity (ADDH): open therapeutic trials". Lucinda G. Miller, PharmD (PI), Irvin A. Kraft, MD (Co-I), Michael Smolensky, PhD (Co-I). Brock-man Charitable Foundation, $27,618. May 1991 - April 1992.
12.       "Evaluation of medication effectiveness in children with attention deficit disorder-hyperactivity (ADDH): actigraphical and temperament assessment". Lucinda G. Miller, PharmD (PI), Michael Smolensky, PhD (Co-I), Irvin A. Kraft, MD (Co-I), James Bray PhD (Co-I). American College of Clinical Pharmacy Family Medicine Research Award, $10,000. June 1991-May 1992.
13.       "Psychopharmacologic drug use in adopted patients in a psychiatric outpatient clinic". Lucinda G. Miller, PharmD (PI), Irvin A. Kraft MD (Co-I). Kraft Research Fund, $4,000. May-September 1991.
14.       "A retrospective review of psychopharmacologic drug use in the outpatient setting". Lucinda G. Miller, PharmD (PI), Irvin A. Kraft, MD (Co-I). Nova Pharmaceutical Corp., $10,000. September 1991-January 1992, Upjohn Pharmaceutical Company, $5,000. February 1992-July 1992.
15.       "Evaluation of medication effectiveness in children with attention deficit hyperactivity disorder (ADHD): actigraphical and T.O.V.A. assessments". Lucinda G. Miller, PharmD (PI), Irvin A. Kraft, MD (Co-I). The T.O.V.A. Research Foundation, $900. July 1992-December 1992.
16.       "Actigraphical evaluation of children: chronobiology and attention deficit hyperactivity disorder (ADHD)". Lucinda G. Miller, Pharm.D. (PI), Irvin A. Kraft, MD (Co-I). The Tapick Foundation, $3,780. October 1992.
17.       "Clinical decision making: Pharmacotherapeutics and cost-effectiveness training for family medicine residents", Michael Crouch, MD (PI), Lucinda G Miller, PharmD. (Component Director), NIH 3 DIS PE 1601-0851. Priority Score- 115; Approved, $120,000, July 1993. (not transferrable when I moved to UNMC in September 1993).
18.       "Pharmaceutical care in rural community pharmacy clerkships: emphasis on developing computer skills to enhance patient education." Lucinda Miller, PharmD (PI), Dave Scott, PhD (Co-I), Paul Jungnickel, PhD (Co-I), American Association of Colleges of Pharmacy (GAPS), $33,182, June 30, 1994-June 30. 1995.
19.       "Reimbursement for pharmacy cognitive services." David M. Scott, PhD (PI), Lucinda G. Miller, PharmD (Co-I), National Association of Retail Druggists (NARD) Foundation, $7,950, June 1, 1994-August 31, 1994.
20.       "A comparative evaluation of oral contraceptive use." Lucinda G. Miller, PharmD (PI), The Upjohn Company, $9,500, June 1, 1994-December 31, 1994.
21.       "Documentation of pharmaceutical care in rural community pharmacies: how pharmaceutical care promotes improved drug usage", Lucinda G. Miller, PharmD (PI), David M Scott, PhD (Co-I), National Association of Retail Druggists (NARD) Foundation, $8,900, October 1, 1994-January 31, 1995.
22. "Freedom of choice insurance issues for reimbursement of pharmacy
services", David M Scott, PhD (PI), Lucinda G. Miller, PharmD (Co‑
I), National Association of Retail Druggists (NARD) Foundation,
$1,100, October 1, 1994-January 31, 1995.
23.       "Adverse effects of sertraline versus fluoxetine in the context of MMPI-2
data" Lucinda G. Miller, PharmD (PI) and Teri Gabel, PharmD (Co-I),
Pfizer Roerig Pharmaceuticals, $8,600, December 15, 1994-June 15,
1996.
24.       "Pharmaceutical care preceptor training and assessment in community pharmacy clerkship sites" Scott DM (PI), Miller LG (Co-I), Jungnickel PW, Galt KA, Maloley PA, Ranno AE, Barr C, $31,966, American Association of Colleges of Pharmacy (GAPS) June 1995-June 1996.
25.       "What relieves persistent maladaptive and antisocial behavior continuity? Temporal youth perceptions of intervention effectiveness and habilitation outcomes. $375,000, Hill JW (PI), Hendricks SE, Silver LB, Miller LG (Research Associate), Irvin D, Esser T, Long N. NIH, submitted May1998.
26.       "Evaluation of echinacea's potential interaction with cytochrome p450 enzymes", $18,000. Miller LG (PI), Fisher C. Professional Health Products, Ltd., submitted January 1998.
27.       "P450 mediated drug interactions with herbal medicines. $373,413, Miller LG (PI), Fisher C. National Cancer Institute, submitted October 1998.
B.        National Scientific Participation

Home | Library Index